ArticleInternational journal of nanomedicine2022

Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice.

Muhammed A Saad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.